Joshua Makower

Insider Reports History

Location
Mountain View, CA
Signature
/s/ Louis Citron, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joshua Makower:

Form 4 holding 10%+ Owner

Bright Health Group Inc.

Security class
Common Stock
Shares / value
23,983,073
Estimated value
$147,256,068
Report date
28 Jun 2021
Price
$6.14
Ownership
Indirect
Form 4 holding Director, 10%+ Owner

Robinhood Markets, Inc.

Security class
Common Stock
Shares / value
2,509,120
Estimated value
$86,120,777
Report date
29 Jul 2021
Price
$34.32
Ownership
Indirect
Form 4 holding 10%+ Owner

Desktop Metal, Inc.

Security class
Class A Common Stock
Shares / value
2,285
Estimated value
$1,675
Report date
08 Jun 2021
Price
$0.7332
Ownership
Indirect
Form 4 holding Director

Eargo, Inc.

Security class
Stock Options (Right to Buy)
Shares / value
74,074
Estimated value
Report date
12 Oct 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Bright Health Group Inc.

Security class
Series A Preferred
Shares / value
0
Estimated value
Report date
28 Jun 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Bright Health Group Inc.

Security class
Series B Preferred
Shares / value
0
Estimated value
Report date
28 Jun 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Bright Health Group Inc.

Security class
Series C Preferred
Shares / value
0
Estimated value
Report date
28 Jun 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Bright Health Group Inc.

Security class
Series D Preferred
Shares / value
0
Estimated value
Report date
28 Jun 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Bright Health Group Inc.

Security class
Series E Preferred
Shares / value
0
Estimated value
Report date
28 Jun 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Monte Rosa Therapeutics, Inc.

Security class
Series A-2 convertible preferred stock
Shares / value
0
Estimated value
Report date
28 Jun 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Monte Rosa Therapeutics, Inc.

Security class
Series B convertible preferred stock
Shares / value
0
Estimated value
Report date
28 Jun 2021
Price
$2.00
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Monte Rosa Therapeutics, Inc.

Security class
Series C convertible preferred Stock
Shares / value
0
Estimated value
Report date
28 Jun 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Joshua Makower

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .